FindTrial
Sign In

Tumor site is a risk factor for hepatocellular carcinoma after hepatectomy: a 1: 2 propensity score matching analysis

Tumor site is a risk factor for hepatocellular carcinoma after hepatectomy: a 1: 2 propensity score matching analysis

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100052407
Enrollment
Unknown
Registered
2021-10-25
Start date
2021-11-01
Completion date
Unknown
Last updated
2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hepatocellular carcinoma

Interventions

Right liver tumor group:tumor in the right liver
left liver tumor group:tumor in the left liver

Sponsors

West China Hospital of Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Patients who have not received other treatments before liver resection; 2. Hepatectomy is limited to left or right liver; 3. Child-pugh stage A or stage B patients; 4. The heart and lung functions are normal and can withstand surgery.

Exclusion criteria

Exclusion criteria: 1. Patients with positive tumor margins; 2. Patients with recurrence within 1 month after operation; 3. Patients who died within 3 months after surgery; 4. Patients with other malignant tumors; 5. HCV infected persons; 6. Patients who received radiofrequency ablation before surgery or other adjuvant therapy during surgery.

Design outcomes

Primary

MeasureTime frame
Disease free survival;Overall survival;—

Countries

China

Contacts

Public ContactZhang Ming

West China Hospital of Sichuan University

48284728@qq.com+86 18980606723

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 18, 2026